Skip to main content
News Directory 3
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World

Infant Formula Recalled: Botulism Investigation

November 12, 2025 Victoria Sterling Business
News Context
At a glance
  • On ⁢February 28, 2024, ByHeart, a direct-to-consumer infant formula⁤ company, initiated a voluntary recall of two specific batches of its Whole⁤ Nutrition Infant Formula.
  • Consumers can‍ find the batch number and best by date printed on‍ the⁤ bottom of the can.
  • Infant botulism is a rare illness ⁣caused by⁣ the bacterium Clostridium botulinum.
Original source: nytimes.com

“`html

ByHeart Infant Formula ⁣Recall: Botulism Concerns⁤ and What Parents Need to Know

Table of Contents

  • ByHeart Infant Formula ⁣Recall: Botulism Concerns⁤ and What Parents Need to Know
    • At ⁣a glance
    • What Happened: the ByHeart Formula‍ Recall
    • Understanding Infant botulism
    • What does This Mean⁣ for Parents?
    • ByHeart’s Response and Ongoing Investigation

Updated February 29, 2024

At ⁣a glance

  • What: Voluntary recall of two batches of ByHeart Whole Nutrition Infant Formula due⁢ to a cluster of infant botulism ‍cases.
  • Where: ⁢Nationwide distribution ‍in the United States.
  • When: Recall ⁢announced February 28, 2024.
  • Why it Matters: Infant botulism is a serious illness that can cause muscle weakness, difficulty breathing, and even death.
  • What’s Next: ⁣parents should immediately stop using the⁢ recalled formula⁤ and contact their healthcare provider.

What Happened: the ByHeart Formula‍ Recall

On ⁢February 28, 2024, ByHeart, a direct-to-consumer infant formula⁤ company, initiated a voluntary recall of two specific batches of its Whole⁤ Nutrition Infant Formula. This action followed ⁤reports of an increase in cases of infant botulism, a rare but serious illness, among infants who had consumed ⁤the ⁤product. The recall was made in cooperation with the Food and Drug Administration (FDA) and the Centers for⁣ Disease Control and Prevention (CDC).

The⁣ affected batches‍ are:

Batch Number Best By Date UPC Code
24181 08/08/2024 850033236089
24190 08/10/2024 850033236089

Consumers can‍ find the batch number and best by date printed on‍ the⁤ bottom of the can.

Understanding Infant botulism

Infant botulism is a rare illness ⁣caused by⁣ the bacterium Clostridium botulinum. Unlike adult botulism, which ⁣ofen results ⁣from improperly canned foods, ‍infant botulism typically occurs when infants⁢ ingest spores of the bacteria. These spores can germinate ‍in the infant’s immature digestive system, producing⁣ a hazardous neurotoxin.

Symptoms of infant botulism can include:

  • Constipation
  • Weak cry
  • Lethargy (floppiness)
  • Difficulty feeding
  • Weakness
  • Difficulty breathing

Early diagnosis and treatment ⁤with antitoxin are crucial. If ⁤you suspect your infant has botulism, seek immediate medical attention.

What does This Mean⁣ for Parents?

The FDA and CDC are currently investigating the source of the Clostridium botulinum ⁤ contamination. While the‍ investigation‍ is ongoing, the ⁤immediate priority is⁣ to protect infants. Parents and caregivers who⁢ have purchased the recalled ByHeart formula ⁢should immediately discontinue use and dispose of the product.

do⁣ not attempt⁢ to return the ⁢formula to the store.contact byheart directly for ⁣a refund or replacement.

If your infant has⁣ consumed the ⁤recalled formula and is exhibiting any symptoms of botulism, contact your pediatrician or seek emergency ‍medical care immediately. Early intervention substantially improves outcomes.

ByHeart’s Response and Ongoing Investigation

ByHeart has stated that it is cooperating fully with the FDA and⁤ CDC investigation. The company has⁢ paused‍ production of‍ the affected batches and⁣ is working to determine the⁣ root cause of the ⁤contamination. ⁢ ByHeart emphasizes its commitment to infant safety and quality control.

We‍ are⁣ deeply ⁤concerned ⁢by⁢ these reports and are taking every‍ possible step ⁤to protect the infants we⁤ serve.Our ⁤commitment to quality and safety remains⁢ unwavering.

The FDA is⁢ conducting a thorough review‍ of ByHeart’s ⁤manufacturing processes and quality control procedures. The investigation will likely focus on identifying potential sources of contamination, including raw materials,

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

News Directory 3

News Directory 3 catalogs US newspapers, news services, newsstands and digital news outlets across all 50 states. Browse local publishers by city, state, or topic, and follow current headlines linked back to their original sources.

Quick Links

  • Disclaimer
  • Terms and Conditions
  • About Us
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Editorial Guidelines
  • Privacy Policy

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

© 2026 News Directory 3. All rights reserved.
For contact, advertising, copyright, issues email: office@newsdirectory3.com